Join

Compare · CBOE vs FLACU

CBOE vs FLACU

Side-by-side comparison of Cboe Global Markets, Inc. (CBOE) and Frazier Lifesciences Acquisition Corporation (FLACU): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CBOE and FLACU operate in n/a (n/a), so they compete in similar markets.
  • CBOE carries a market cap of $13.01B.
  • CBOE has hit the wire 3 times in the past 4 weeks while FLACU has been quiet.
  • CBOE has more recent analyst coverage (25 ratings vs 0 for FLACU).
MetricCBOEFLACU
Company
Cboe Global Markets, Inc.
Frazier Lifesciences Acquisition Corporation
Price
$303.52+0.98%
$9.51-1.04%
Market cap
$13.01B
-
1M return
+9.45%
-
1Y return
+43.01%
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
2010
2020
News (4w)
3
0
Recent ratings
25
0
CBOE

Cboe Global Markets, Inc.

Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, European Equities, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities; and offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The European Equities segment offers pan-European listed equities transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.

FLACU

Frazier Lifesciences Acquisition Corporation

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Latest CBOE

Latest FLACU